Komori
Business alliance2784Alfresa Holdings CorporationTrading & Wholesale

Alfresa Corporation, 株式会社12薬局 and animo株式会社 Reach Basic Agreement on Commercializing a Next-Generation Animal Healthcare Platform

The 3 companies, アルフレッサ, 12薬局 and animo, have reached a basic agreement on commercializing a next-generation animal healthcare platform connecting veterinary hospitals with pet owners. They will discuss the development of dispensing services using online prescriptions, an information-sharing infrastructure, and services in the veterinary healthcare field.

Worth reading
32Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Avoiding a definitive answer
How definitive the wording is.

Agreements reached under this partnership

Business alliance
2784Alfresa Holdings Corporation
Alliance partner株式会社12薬局 / animo株式会社
Details of the alliance
  1. 1

    Development of systems for dispensing services using online prescriptions and other tools for veterinary hospitals and pet owners

  2. 2

    Development of an information-sharing infrastructure through the above systems

  3. 3

    Business planning and service development in the veterinary healthcare sector

These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.

About the partner
Business DescriptionOperation of a veterinary dispensing pharmacy Retail and wholesale distribution of pharmaceuticals and medical supplies Planning, development, sale and maintenance of computer systems / Business support in the animal healthcare sector Provision of the “animo platform,” which connects pet owners with veterinarians and other professionals
LocationSetagaya-ku, Tokyo / Hokuto City, Yamanashi Prefecture
Share capital¥92 million / ¥15 million
Impact on Business Performance

The impact of this transaction on performance for the current fiscal year is expected to be immaterial, but the Company believes it will contribute to enhancing the corporate value of the Group over the medium to long term.

Contract Date25 August 2026
Agreements reached under this partnership
ItemDetails
Name of alliance partner株式会社12薬局, animo株式会社
Alliance partner's business activitiesOperation of a veterinary dispensing pharmacy Retail and wholesale distribution of pharmaceuticals and medical supplies Planning, development, sale and maintenance of computer systems, Business support in the animal healthcare sector Provision of the “animo platform,” which connects pet owners with veterinarians and other professionals
Alliance partner's locationSetagaya-ku, Tokyo, Hokuto City, Yamanashi Prefecture
Alliance partner's capital¥92 million, ¥15 million
Type of allianceBusiness alliance
Details of the allianceDevelopment of systems for dispensing services using online prescriptions and other tools for veterinary hospitals and pet owners, Development of an information-sharing infrastructure through the above systems, Business planning and service development in the veterinary healthcare sector
Contract Date25 August 2026
Impact on Business PerformanceThe impact of this transaction on performance for the current fiscal year is expected to be immaterial, but the Company believes it will contribute to enhancing the corporate value of the Group over the medium to long term.
Items this document does not state (15)
Alliance partner's net salesAlliance partner's operating incomeNumber of shares acquiredAcquisition priceShareholding ratioOverview of the joint ventureOwnership ratioDispatch of directors and officersContract PeriodNumerical targets under the allianceShareholding PolicyDate of board resolutionAlliance start dateShare Acquisition Date and Payment DateChange in major shareholders

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The companies aim to improve the operational efficiency of veterinary hospitals, enhance convenience for pet owners and create new services in response to growing demand for animal health management as pets increasingly become regarded as family members and live longer, the burden on veterinary hospitals of handling related administrative and other services, and rising expectations for services that reduce pet owners' waiting and travel burdens and enable them to monitor their pets' health continuously.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Alfresa Corporation, 株式会社12薬局 and animo株式会社 Reach Basic Agreement on Commercializing a Next-Generation Animal Healthcare Platform | Alfresa Holdings Corporation (2784) timely disclosure | Komori